Agency Forms Undergoing Paperwork Reduction Act Review, 40048-40050 [2021-15792]
Download as PDF
<![CDATA[
40048
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
Zoonotic Infectious Diseases (NCEZID),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
Cryptosporidium are a genus of
parasites that cause the diarrheal
disease cryptosporidiosis. As part of
Cryptosporidium case and outbreak
investigations, it is common for state
and local health departments to conduct
comprehensive interviews with cases
and contacts to identify how individuals
became sick with cryptosporidiosis, to
identify individuals who could have
come into contact with an individual
sick with cryptosporidiosis, and to
identify strategies to control the disease
spread. Since cryptosporidiosis can be
transmitted through numerous modes, it
can be challenging to identify how
individuals could have become ill. As a
result, comprehensive case report forms
focused on a range of settings, activities,
and potential modes of transmission are
needed to guide prevention and control
activities.
The CryptoNet case report form (CRF)
was developed to meet the needs of
CDC’s case surveillance experts and
local officials. The CRF includes a set of
data elements that can be used to
identify exposure trends in outbreakand non-outbreak-associated
Cryptosporidium cases, to generate
hypotheses about the source(s) of
infection in clusters or outbreaks, and to
identify strategies to prevent and control
Cryptosporidium cases, clusters, or
outbreaks. CryptoNet is meant to
supplement existing cryptosporidiosis
case surveillance data reported through
the National Notifiable Diseases
Surveillance System (NNDSS) (OMB
No. 0920–0728, Exp. 3/31/2024).
Current cryptosporidiosis case
surveillance through NNDSS lacks
information on key exposures proposed
to be captured by CryptoNet. Notably,
information proposed to be collected as
part of CryptoNet serves as the
foundation for the recently developed
foodborne and diarrheal diseases
message mapping guide—
cryptosporidiosis tab (FDD MMG). The
FDD MMG is the latest revision to
NNDSS that aims to increase the
amount of exposure data collected on
each cryptosporidiosis case. Upon
nationwide implementation of the FDD
MMG, NCEZID anticipates that the
CryptoNet Case Report form will be
retired.
Administration of the CRF is to
conduct surveillance on exposures
associated with Cryptosporidium cases
to better inform prevention and control
strategies for these infections. There are
no research questions addressed.
Standardized data will be compiled on
recent exposures related to
cryptosporidiosis with the intention to
inform disease prevention and control
activities and will not be used to inform
generalizable knowledge. CDC’s
CryptoNet staff and the Case
Surveillance node in CDC’s Waterborne
Disease Prevention Branch (WDPB) will
oversee data collection, data
management, and analyses and
dissemination of data collected with the
CRF during cryptosporidiosis
investigations. The data collected from
the CRF will be used to inform exposure
trends among cases, clusters, or
outbreaks with the intention to identify
and implement prevention and control
strategies and recommendations.
The CRF data elements and form were
designed for administration via
telephone interview with cases of
cryptosporidiosis or their proxies. This
method was chosen to reduce the
overall burden on respondents because
it allows for the assessment team to ask
for clarification from participants during
the interview, and this limits the need
for additional follow-up. The data
collection instrument was designed to
collect the minimum information
necessary for the purposes of this
project.
Based on the annual number of
laboratory specimens collected by the
Cryptosporidium laboratory at CDC, it is
expected that an average of 500
CryptoNet CRFs will be collected each
year. OMB approval is requested for
three years. Participation is voluntary
and there are no costs to respondents
other than their time. The total
estimated annualized burden is 125
hours.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Individuals ill with Cryptosporidiosis, or their
designated proxy.
CryptoNet Case Report Form ........................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–15790 Filed 7–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
jbell on DSKJLSW7X2PROD with NOTICES
Number of
respondents
Type of respondent
[30Day–21–1169]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Development
of CDC’s Let’s Stop HIV Together Social
Marketing Campaign for Consumers’’ to
the Office of Management and budget
(OMB) for review and approval. CDC
previously published a ‘‘Proposed Data
Collection Submitted for Public
Comment and Recommendations’’
notice on March 12, 2021 to obtain
comments from the public and affected
agencies. CDC did not receive comments
related to the previous notice. This
notice serves to allow an additional 30
days for public and affected agency
comments.
CDC will accept all comments for this
proposed information collection project.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
500
Number of
responses per
respondent
1
Average
burden per
response
(in hours)
15/60
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
E:\FR\FM\26JYN1.SGM
26JYN1
40049
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Development of CDC’s Let’s Stop HIV
Together Social Marketing Campaign for
Consumers—Reinstatement—National
Center for HIV/AIDS, Viral Hepatitis,
STD and TB Prevention (NCHHSTP),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
To address the HIV epidemic in the
U.S., the Department of Health and
Human Services launched Ending the
HIV Epidemic: A Plan for America,
which is a cross-agency initiative
aiming to reduce new HIV infections in
the U.S. by 90% by 2030. CDC’s Let’s
Stop HIV Together campaign (formerly
known as Act Against AIDS) is part of
the national Ending the HIV Epidemic
initiative and includes resources aimed
at reducing HIV stigma and promoting
testing, prevention, and treatment across
the HIV care continuum.
Within this context, CDC’s Division of
HIV/AIDS Prevention (DHAP) has and
will continue implementing various
communication initiatives to increase
HIV awareness among the general
public, reduce new HIV infections
among disproportionately impacted
populations, and improve health
outcomes for people living with HIV/
AIDS in the US and its territories.
Specifically, the campaigns target
consumers aged 18 to 64 years old and
includes the following audiences: (1)
General public; (2) Men who have sex
with men; (3) Blacks/African
Americans; (4) Hispanics/Latinos; (5)
Transgender individuals; (6) people
who inject drugs; and (7) people with
HIV (PWH).
The rounds of data collection include
exploratory, message testing, concept
testing, and materials testing.
Information collected by DHAP will be
used to assess consumers’ informational
needs about HIV testing, prevention,
and treatment and pre-test campaign
related messages, concepts, and
materials and evaluate the extent to
which the communication initiatives are
reaching the target audiences and
providing them with trusted HIV-related
information. Data collections will
include in-depth interviews, focus
groups, brief surveys, and intercept
interviews.
The data gathered under this request
will be summarized in reports prepared
for CDC by its contractor, such as
quarterly and annual reports and topline
reports that summarize results from
each data collection. It is possible that
data from this project will be published
in peer-reviewed manuscripts or
presented at conferences; the
manuscripts and conference
presentations may appear on the
internet.
The total estimated annualized
burden hours are 1,856. Participation by
respondents is voluntary, and there is
no cost to participants other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
jbell on DSKJLSW7X2PROD with NOTICES
Health care providers.
VerDate Sep<11>2014
Number of
respondents
Form name
Number of
responses per
respondent
Average
burden per
response
(in hours)
Study screener ........................................................................................
2,165
1
2/60
Exploratory—HIV Testing In-depth Interview ..........................................
Exploratory—HIV Prevention In-depth Interview ....................................
Exploratory—HIV Communication and Awareness In-depth Interview ..
Exploratory—HIV Prevention with Positives In-depth Interview .............
Message Testing In-depth Interview .......................................................
Concept Testing In-depth Interview ........................................................
Materials Testing In-depth Interview .......................................................
Exploratory—HIV Testing Focus Group ..................................................
Exploratory—HIV Prevention Focus Group ............................................
Exploratory—HIV Communication and Awareness Focus Group ..........
Exploratory—HIV Prevention with Positives Focus Group .....................
Concept Testing Focus Group ................................................................
Message Testing Focus Group ...............................................................
Materials Testing Focus Group ...............................................................
HIV Testing Survey .................................................................................
HIV Prevention Survey ............................................................................
HIV Communication and Awareness Survey ..........................................
HIV Prevention with Positives Survey .....................................................
Intercept Interview ...................................................................................
50
52
50
50
50
50
50
74
74
74
74
68
68
68
213
213
213
213
657
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
15/60
15/60
15/60
15/60
20/60
17:10 Jul 23, 2021
Jkt 253001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\26JYN1.SGM
26JYN1
40050
Federal Register / Vol. 86, No. 140 / Monday, July 26, 2021 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–15792 Filed 7–23–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–21–0800; Docket No. CDC–2021–
0072]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communication Campaigns.
CDC is requesting a Revision to this
Generic Clearance to include an
additional cancer-related
communications campaign, expand the
modes of data collection to include
online focus groups and in-depth
interviews (in-person, phone, and
online), and to focus on respondents
from the general public.
DATES: CDC must receive written
comments on or before September 24,
2021.
SUMMARY:
You may submit comments,
identified by Docket No. CDC–2021–
0072 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
jbell on DSKJLSW7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
17:10 Jul 23, 2021
Jkt 253001
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected;
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses; and
5. Assess information collection costs.
Proposed Project
Focus Group Testing to Effectively
Plan and Tailor Cancer Prevention and
Control Communications Campaigns—
(OMB Control No. 0920–0800, Exp. 10/
31/2021)—Revision—National Center
for Chronic Disease Prevention and
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Health Promotion (NCCDPHP), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The mission of the CDC’s Division of
Cancer Prevention and Control (DCPC)
is to reduce the burden of cancer in the
United States through cancer
prevention, reduction of risk, early
detection, and improved quality of life
for cancer survivors. Toward this end,
the DCPC supports the scientific
development and implementation of
various health communication
campaigns with an emphasis on specific
cancer burdens.
This process requires testing of
messages, concepts, and materials prior
to their final development and
dissemination, as described in the
second step of the health
communication process. The health
communication process is a scientific
model developed by the U.S.
Department of Health and Human
Services’ National Cancer Institute to
guide sound campaign development.
The communication literature supports
various data collection methods to
conduct credible formative, concept,
message, and materials testing. This
process ensures that the public clearly
understands cancer-specific information
and concepts, are motivated to take the
desired action, and do not react
negatively to the messages. CDC is
currently approved to collect
information needed to plan and tailor
cancer communication campaigns (OMB
Control No. 0920–0800, Exp. 10/31/
2021), and seeks OMB approval to
revise the existing generic clearance to
include another cancer-related
communications campaign, expand the
modes of data collection to include
online focus groups and in-depth
interviews (in-person, phone, and
online), and to focus on respondents
from the general public.
Information collection will involve
discussions to assess numerous
qualitative dimensions of cancer
prevention and control messages
including, but not limited to, cancer
knowledge, attitudes, beliefs, behavioral
intentions, information needs and
sources, and compliance with cancer
screening as recommended by the
United States Preventive Services Task
Force. Insights gained from these
discussions will assist in the
development and/or refinement of
future campaign messages and
materials. Communication campaigns
and messages will vary according to the
type of cancer and the qualitative
dimensions of the message described
above. A separate information collection
E:\FR\FM\26JYN1.SGM
26JYN1
]]>Agencies
[Federal Register Volume 86, Number 140 (Monday, July 26, 2021)]
[Notices]
[Pages 40048-40050]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15792]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-21-1169]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``Development of CDC's Let's Stop HIV
Together Social Marketing Campaign for Consumers'' to the Office of
Management and budget (OMB) for review and approval. CDC previously
published a ``Proposed Data Collection Submitted for Public Comment and
Recommendations'' notice on March 12, 2021 to obtain comments from the
public and affected agencies. CDC did not receive comments related to
the previous notice. This notice serves to allow an additional 30 days
for public and affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who
[[Page 40049]]
are to respond, including, through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Development of CDC's Let's Stop HIV Together Social Marketing
Campaign for Consumers--Reinstatement--National Center for HIV/AIDS,
Viral Hepatitis, STD and TB Prevention (NCHHSTP), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
To address the HIV epidemic in the U.S., the Department of Health
and Human Services launched Ending the HIV Epidemic: A Plan for
America, which is a cross-agency initiative aiming to reduce new HIV
infections in the U.S. by 90% by 2030. CDC's Let's Stop HIV Together
campaign (formerly known as Act Against AIDS) is part of the national
Ending the HIV Epidemic initiative and includes resources aimed at
reducing HIV stigma and promoting testing, prevention, and treatment
across the HIV care continuum.
Within this context, CDC's Division of HIV/AIDS Prevention (DHAP)
has and will continue implementing various communication initiatives to
increase HIV awareness among the general public, reduce new HIV
infections among disproportionately impacted populations, and improve
health outcomes for people living with HIV/AIDS in the US and its
territories. Specifically, the campaigns target consumers aged 18 to 64
years old and includes the following audiences: (1) General public; (2)
Men who have sex with men; (3) Blacks/African Americans; (4) Hispanics/
Latinos; (5) Transgender individuals; (6) people who inject drugs; and
(7) people with HIV (PWH).
The rounds of data collection include exploratory, message testing,
concept testing, and materials testing. Information collected by DHAP
will be used to assess consumers' informational needs about HIV
testing, prevention, and treatment and pre-test campaign related
messages, concepts, and materials and evaluate the extent to which the
communication initiatives are reaching the target audiences and
providing them with trusted HIV-related information. Data collections
will include in-depth interviews, focus groups, brief surveys, and
intercept interviews.
The data gathered under this request will be summarized in reports
prepared for CDC by its contractor, such as quarterly and annual
reports and topline reports that summarize results from each data
collection. It is possible that data from this project will be
published in peer-reviewed manuscripts or presented at conferences; the
manuscripts and conference presentations may appear on the internet.
The total estimated annualized burden hours are 1,856.
Participation by respondents is voluntary, and there is no cost to
participants other than their time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per
Type of respondent Form name respondents responses per response (in
respondent hours)
----------------------------------------------------------------------------------------------------------------
Health care providers............... Study screener............ 2,165 1 2/60
Exploratory--HIV Testing 50 1 1
In-depth Interview.
Exploratory--HIV 52 1 1
Prevention In-depth
Interview.
Exploratory--HIV 50 1 1
Communication and
Awareness In-depth
Interview.
Exploratory--HIV 50 1 1
Prevention with Positives
In-depth Interview.
Message Testing In-depth 50 1 1
Interview.
Concept Testing In-depth 50 1 1
Interview.
Materials Testing In-depth 50 1 1
Interview.
Exploratory--HIV Testing 74 1 2
Focus Group.
Exploratory--HIV 74 1 2
Prevention Focus Group.
Exploratory--HIV 74 1 2
Communication and
Awareness Focus Group.
Exploratory--HIV 74 1 2
Prevention with Positives
Focus Group.
Concept Testing Focus 68 1 2
Group.
Message Testing Focus 68 1 2
Group.
Materials Testing Focus 68 1 2
Group.
HIV Testing Survey........ 213 1 15/60
HIV Prevention Survey..... 213 1 15/60
HIV Communication and 213 1 15/60
Awareness Survey.
HIV Prevention with 213 1 15/60
Positives Survey.
Intercept Interview....... 657 1 20/60
----------------------------------------------------------------------------------------------------------------
[[Page 40050]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-15792 Filed 7-23-21; 8:45 am]
BILLING CODE 4163-18-P
